Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer
Basal subtype predicts clinical benefit from neoadjuvant chemo in urothelial cancer
A short tour of the p-medicine Biovista Correlation Viewer Tool
A short tour of the p-medicine ObTiMA Tool
Optimizing survival in advanced prostate cancer: Welcome and introduction
Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival
Latest achievements in the p-medicine project
Supportive cancer care: goals and guidelines
Futures in cancer nursing care around the world
The p-medicine project and personalised medicine
New approaches and new partnership models for biomarker based clinical research
Cancer prevention and palliation are the new frontiers of cancer control